BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20656485)

  • 1. Factorizing the role of a critical leucine residue in the binding of substrate to human 20alpha-hydroxysteroid dehydrogenase (AKR1C1): molecular modeling and kinetic studies of the Leu308Val mutant enzyme.
    Dhagat U; Endo S; Soda M; Hara A; El-Kabbani O
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5274-6. PubMed ID: 20656485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based optimization and biological evaluation of human 20α-hydroxysteroid dehydrogenase (AKR1C1) salicylic acid-based inhibitors.
    El-Kabbani O; Scammells PJ; Day T; Dhagat U; Endo S; Matsunaga T; Soda M; Hara A
    Eur J Med Chem; 2010 Nov; 45(11):5309-17. PubMed ID: 20850205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1).
    El-Kabbani O; Scammells PJ; Gosling J; Dhagat U; Endo S; Matsunaga T; Soda M; Hara A
    J Med Chem; 2009 May; 52(10):3259-64. PubMed ID: 19397269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1).
    El-Kabbani O; Dhagat U; Hara A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):105-11. PubMed ID: 21050889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the inhibitor selectivity pocket of human 20α-hydroxysteroid dehydrogenase (AKR1C1) with X-ray crystallography and site-directed mutagenesis.
    El-Kabbani O; Dhagat U; Soda M; Endo S; Matsunaga T; Hara A
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2564-7. PubMed ID: 21414777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of the physiological interconversion of 5alpha-DHT and 3alpha-diol by rat 3alpha-HSD via transient kinetics shows that the chemical step is rate-determining: effect of mutating cofactor and substrate-binding pocket residues on catalysis.
    Heredia VV; Penning TM
    Biochemistry; 2004 Sep; 43(38):12028-37. PubMed ID: 15379543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human 20alpha-hydroxysteroid dehydrogenase: crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids.
    Couture JF; Legrand P; Cantin L; Luu-The V; Labrie F; Breton R
    J Mol Biol; 2003 Aug; 331(3):593-604. PubMed ID: 12899831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human 3-alpha hydroxysteroid dehydrogenase type 3 (3α-HSD3): the V54L mutation restricting the steroid alternative binding and enhancing the 20α-HSD activity.
    Zhang B; Zhu DW; Hu XJ; Zhou M; Shang P; Lin SX
    J Steroid Biochem Mol Biol; 2014 May; 141():135-43. PubMed ID: 24434280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of homogeneous recombinant rat ovarian 20alpha-hydroxysteroid dehydrogenase: fluorescent properties and inhibition profile.
    Ma H; Penning TM
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):853-9. PubMed ID: 10417353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences.
    Jin Y; Penning TM
    Steroids; 2006 May; 71(5):380-91. PubMed ID: 16455123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivatives of pyrimidine, phthalimide and anthranilic acid as inhibitors of human hydroxysteroid dehydrogenase AKR1C1.
    Brozic P; Cesar J; Kovac A; Davies M; Johnson AP; Fishwick CW; Lanisnik Rizner T; Gobec S
    Chem Biol Interact; 2009 Mar; 178(1-3):158-64. PubMed ID: 19007763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse 17alpha-hydroxysteroid dehydrogenase (AKR1C21) binds steroids differently from other aldo-keto reductases: identification and characterization of amino acid residues critical for substrate binding.
    Faucher F; Cantin L; Pereira de Jésus-Tran K; Lemieux M; Luu-The V; Labrie F; Breton R
    J Mol Biol; 2007 Jun; 369(2):525-40. PubMed ID: 17442338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of mammalian 3alpha-hydroxysteroid dehydrogenase to 20alpha-hydroxysteroid dehydrogenase using loop chimeras: changing specificity from androgens to progestins.
    Ma H; Penning TM
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11161-6. PubMed ID: 10500147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3.
    Beranič N; Gobec S; Rižner TL
    Chem Biol Interact; 2011 May; 191(1-3):227-33. PubMed ID: 21182831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone metabolism in adipose cells.
    Zhang Y; Nadeau M; Faucher F; Lescelleur O; Biron S; Daris M; Rhéaume C; Luu-The V; Tchernof A
    Mol Cell Endocrinol; 2009 Jan; 298(1-2):76-83. PubMed ID: 18984031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1.
    Brozic P; Smuc T; Gobec S; Rizner TL
    Mol Cell Endocrinol; 2006 Oct; 259(1-2):30-42. PubMed ID: 16962702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural importance of the C-terminal region in pig aldo-keto reductase family 1 member C1 and their effects on enzymatic activity.
    Son M; Park C; Kwon SG; Bang WY; Kim SW; Kim CW; Lee KW
    BMC Struct Biol; 2015 Jan; 15():1. PubMed ID: 25583233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reactive oxygen species--and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene.
    Burczynski ME; Sridhar GR; Palackal NT; Penning TM
    J Biol Chem; 2001 Jan; 276(4):2890-7. PubMed ID: 11060293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alanine scanning mutagenesis of the testosterone binding site of rat 3 alpha-hydroxysteroid dehydrogenase demonstrates contact residues influence the rate-determining step.
    Heredia VV; Cooper WC; Kruger RG; Jin Y; Penning TM
    Biochemistry; 2004 May; 43(19):5832-41. PubMed ID: 15134457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of human Delta4-3-ketosteroid 5beta-reductase (AKR1D1) reveal the presence of an alternative binding site responsible for substrate inhibition.
    Faucher F; Cantin L; Luu-The V; Labrie F; Breton R
    Biochemistry; 2008 Dec; 47(51):13537-46. PubMed ID: 19075558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.